2m 2m 2m 2m 2m 2m 2m
GENPREX (GNPX)
NASDAQ
$0.51-$0.02 (-4.52%)
Price as of Jul 14, 2026 4:46 AM EDT- $5.8MMarket Cap
- -96.43%1-Year Change
- BiotechnologyIndustry
GENPREX (GNPX)
$0.51-$0.02 (-4.52%)
GNPX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.54 | ||
Change | -$0.02 (-4.41%) | ||
Open | $0.56 | ||
High | $0.56 | ||
Low | $0.53 | ||
Previous Close | $0.56 | ||
Volume | 96,778 | ||
30-Day Average Volume | 397,211 | ||
1-Week Change | -13.82% | ||
1-Month Change | -16.40% | ||
1-Year Change | -96.43% | ||
3-Year Change | -99.97% | ||
5-Year Change | -99.99% | ||
Fundamentals | |||
Shares Outstanding | 10.9M | ||
Total Assets | $20.3M | ||
Market Cap | $5.8M | ||
Enterprise Value | -$12.2M | ||
Period: QTR TTM FY | |||
Revenue | $541.00 | ||
Net Income | -$4.5M | ||
Free Cash Flow | -$3.1M | ||
EBIT | -$4.5M | ||
EBITDA | -$4.5M | ||
Net Working Capital | $15.4M | ||
EPS | -$0.64 | ||
Enterprise Value/EBITDA | 3 | ||
Enterprise Value/Revenue | -22,553 | ||
P/B | 0 | ||
P/E | -1 | ||
PEG | 0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 50 | ||
Last Split Date | 10/21/2025 | ||
Earnings & Revenue